Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Post by thisisriskystufon Nov 27, 2017 5:10pm

198 Views

Post# 27041528

Stock Price

Some people are very upset about the price of this stock- imho it should be around $8.25 to $8.75 - I am not selling my shares but Dec is just around the corner and tax losses are coming sure hope this stock stands up as many people may just sell and move on to a stock that will move with the market. I am a late investor but hanging on for the ride and I am hoping for a happy journey, one up and away. :) GLTL

Bullboard Posts

3 Mid-Sized Stocks to Consider This Season